ASCO Clinical Notice: Recommending Against Ivermectin and Fenbendazole for Cancer Treatment, Outside of Clinical Trials | ASCO Connection connection.asco.org/do/asco-clin...
connection.asco.org
ASCO Clinical Notice: Recommending Against Ivermectin and Fenbendazole for Cancer Treatment, Outside of Clinical Trials
In a May 2026 Clinical Notice, ASCO strongly cautions that ivermectin and fenbendazole should not be used for the treatment of cancer, nor as an adjunct to established cancer therapies, outside the re...